Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026571 · ClinicalTrials.gov registry record
Identification of Genetic Causes of Bicuspid Aortic Valve Disease
A clinical trial of Bicuspid Aortic Valve, sponsored by Boston University.
- Active
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT01026571 is a study of Bicuspid Aortic Valve that is active but no longer recruiting, run by Boston University. The registered enrollment target is 4,000 participants, above the 1,850-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01026571, a study of Bicuspid Aortic Valve, is active but no longer recruiting, sponsored by Boston University.
- ACTIVE NOT RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
BAVgenetics is a partnership between Investigators at Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital dedicated to discovering the genetic causes of bicuspid aortic valve disease and associated aortic disease.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2009-12 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01026571
The ClinicalTrials.gov registry entry for NCT01026571 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,850-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (116% higher). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bicuspid Aortic Valve appearing as the primary indexed condition, and to 0 interventions.
NCT01026571 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01026571 about?
NCT01026571 is a clinical study titled "Identification of Genetic Causes of Bicuspid Aortic Valve Disease". BAVgenetics is a partnership between Investigators at Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital dedicated to discovering the genetic causes of bicuspid aortic valve disease and associated aortic disease.
What is the current status of trial NCT01026571?
This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2009-12. Estimated completion is 2030-12.
What conditions does trial NCT01026571 study?
This clinical trial studies the following conditions: Bicuspid Aortic Valve.
Who is sponsoring clinical trial NCT01026571?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01026571 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bicuspid Aortic Valve
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bicuspid Aortic Valve (BAV) Registry
RECRUITING
-
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
RECRUITING
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.